Keith Byron

3.4k total citations
32 papers, 786 citations indexed

About

Keith Byron is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Keith Byron has authored 32 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Keith Byron's work include Dermatology and Skin Diseases (3 papers), Cancer Diagnosis and Treatment (3 papers) and Treatment of Major Depression (3 papers). Keith Byron is often cited by papers focused on Dermatology and Skin Diseases (3 papers), Cancer Diagnosis and Treatment (3 papers) and Treatment of Major Depression (3 papers). Keith Byron collaborates with scholars based in Australia, United States and Canada. Keith Byron's co-authors include Andrew Wootton, George A. Varigos, Richard M. O’Brien, Wayne R. Thomas, Leslie J. Sheffield, Carl M. J. Kirkpatrick, George Varigos, Richard W. Tothill, David D.L. Bowtell and Ajeet Singh and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

Keith Byron

31 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Byron Australia 15 199 154 133 127 118 32 786
Jeong‐Hyun Kim South Korea 13 275 1.4× 159 1.0× 57 0.4× 49 0.4× 119 1.0× 72 665
Kuo‐Tung Tang Taiwan 18 108 0.5× 278 1.8× 65 0.5× 52 0.4× 55 0.5× 93 1.2k
Juan Meng China 20 328 1.6× 176 1.1× 319 2.4× 40 0.3× 90 0.8× 79 1.2k
Daniel Lambert France 18 76 0.4× 236 1.5× 39 0.3× 96 0.8× 35 0.3× 37 1.0k
Inimioara Mihaela Cojocaru Romania 16 129 0.6× 221 1.4× 24 0.2× 51 0.4× 113 1.0× 60 1.1k
Anita Balakrishnan United Kingdom 17 245 1.2× 127 0.8× 94 0.7× 209 1.6× 88 0.7× 41 969
Mitsuru Imamura Japan 15 214 1.1× 283 1.8× 75 0.6× 39 0.3× 193 1.6× 25 876
Huanying Wan China 16 225 1.1× 203 1.3× 44 0.3× 100 0.8× 255 2.2× 34 909
Jiong Yang China 20 498 2.5× 207 1.3× 123 0.9× 92 0.7× 243 2.1× 61 1.2k
Zenon Brzoza Poland 19 264 1.3× 61 0.4× 197 1.5× 31 0.2× 64 0.5× 73 1.1k

Countries citing papers authored by Keith Byron

Since Specialization
Citations

This map shows the geographic impact of Keith Byron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Byron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Byron more than expected).

Fields of papers citing papers by Keith Byron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Byron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Byron. The network helps show where Keith Byron may publish in the future.

Co-authorship network of co-authors of Keith Byron

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Byron. A scholar is included among the top collaborators of Keith Byron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Byron. Keith Byron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hongbin, Melissa Byrne, Patrick Perlmutter, et al.. (2019). A Novel Epigenetic Drug-Eluting Balloon Angioplasty Device: Evaluation in a Large Animal Model of Neointimal Hyperplasia. Cardiovascular Drugs and Therapy. 33(6). 687–692. 2 indexed citations
2.
3.
Bousman, Chad, Daniel J. Müller, Chee H. Ng, et al.. (2016). Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder. Pharmacogenetics and Genomics. 27(1). 1–6. 11 indexed citations
4.
Tothill, Richard W., Fan Shi, Justin Bedő, et al.. (2014). Development and validation of a gene expression tumour classifier for cancer of unknown primary. Pathology. 47(1). 7–12. 33 indexed citations
5.
Singh, Ajeet, Chad Bousman, Chee H. Ng, Keith Byron, & Michael Berk. (2013). Psychomotor depressive symptoms may differentially respond to venlafaxine. International Clinical Psychopharmacology. 28(3). 121–126. 13 indexed citations
6.
Ng, Chee H., Jerome Sarris, Ajeet Singh, et al.. (2013). Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression. Human Psychopharmacology Clinical and Experimental. 28(5). 516–522. 34 indexed citations
7.
Dick, Ronald, Anthony E. Dear, & Keith Byron. (2011). Clopidogrel Resistance: Case reports of CYP2C19 gene variants in suspected coronary stent thrombosis. Heart Lung and Circulation. 20(10). 657–658. 3 indexed citations
8.
Restall, Christina M., et al.. (2009). A novel histone deacetylase inhibitor augments tamoxifen‐mediated attenuation of breast carcinoma growth. International Journal of Cancer. 125(2). 483–487. 14 indexed citations
9.
Reid, Susan, Jane Halliday, Michael Ditchfield, et al.. (2005). Factor V Leiden mutation: a contributory factor for cerebral palsy?. Developmental Medicine & Child Neurology. 48(1). 14–19. 17 indexed citations
10.
Dimech, Wayne, D. Scott Bowden, Keith Byron, et al.. (2004). Validation of assembled nucleic acid-based tests in diagnostic microbiology laboratories. Pathology. 36(1). 45–50. 20 indexed citations
11.
Beilin, Jonathan, Laurence Harewood, Mark Frydenberg, et al.. (2001). A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects. Cancer. 92(4). 941–949. 52 indexed citations
12.
Collins, Steven, Alison Boyd, Ashley Fletcher, et al.. (2000). Novel Prion Protein Gene Mutation in an Octogenarian With Creutzfeldt-Jakob Disease. Archives of Neurology. 57(7). 1058–1058. 35 indexed citations
13.
Horton, Stephen, Warwick Butt, Clarke A. Thuys, et al.. (1999). IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating. The Annals of Thoracic Surgery. 68(5). 1751–1755. 33 indexed citations
14.
15.
Byron, Keith, et al.. (1999). A case of spontaneous mutation in the keratin 9 gene associated with epidermolytic palmoplantar keratoderma. Australasian Journal of Dermatology. 40(4). 215–216. 7 indexed citations
16.
Cicuttini, Flavia, Keith Byron, Dermot Maher, et al.. (1995). Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis. Rheumatology International. 14(5). 201–206. 22 indexed citations
17.
Byron, Keith, Richard M. O’Brien, George A. Varigos, & Andrew Wootton. (1994). Dermatophagoides pteronyssinus II‐induced interleukin‐4 and interferon‐γ expression by freshly isolated lymphocytes of atopic individuals. Clinical & Experimental Allergy. 24(9). 878–883. 43 indexed citations
18.
Byron, Keith, George A. Varigos, & Andrew Wootton. (1994). IL-4 production is increased in cigarette smokers. Clinical & Experimental Immunology. 95(2). 333–336. 116 indexed citations
19.
Byron, Keith, et al.. (1992). Interferon-Gamma Production in Atopic Dermatitis: A Role for Prostaglandins?. International Archives of Allergy and Immunology. 99(1). 50–55. 17 indexed citations
20.
Deam, David, Keith Byron, Sujiva Ratnaike, et al.. (1989). ALPHA1-Antitrypsin phenotypes in homosexual men. Pathology. 21(2). 91–92. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeong‐Hyun Kim Breakdown of academic impact, for papers by Kuo‐Tung Tang Breakdown of academic impact, for papers by Juan Meng Breakdown of academic impact, for papers by Daniel Lambert Breakdown of academic impact, for papers by Inimioara Mihaela Cojocaru Breakdown of academic impact, for papers by Anita Balakrishnan Breakdown of academic impact, for papers by Mitsuru Imamura Breakdown of academic impact, for papers by Huanying Wan Breakdown of academic impact, for papers by Jiong Yang Breakdown of academic impact, for papers by Zenon Brzoza
Rankless by CCL
2026